164 related articles for article (PubMed ID: 36077069)
21. Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer.
Jala VR; Radde BN; Haribabu B; Klinge CM
BMC Cancer; 2012 Dec; 12():624. PubMed ID: 23273253
[TBL] [Abstract][Full Text] [Related]
22. G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer.
Lee SJ; Kim TW; Park GL; Hwang YS; Cho HJ; Kim JT; Lee HG
BMB Rep; 2019 Nov; 52(11):647-652. PubMed ID: 31234952
[TBL] [Abstract][Full Text] [Related]
23. GPER Mediates Non-Genomic Effects of Estrogen.
Pupo M; Maggiolini M; Musti AM
Methods Mol Biol; 2016; 1366():471-488. PubMed ID: 26585158
[TBL] [Abstract][Full Text] [Related]
24. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
[TBL] [Abstract][Full Text] [Related]
25. G protein-coupled estrogen receptor is required for the neuritogenic mechanism of 17β-estradiol in developing hippocampal neurons.
Ruiz-Palmero I; Hernando M; Garcia-Segura LM; Arevalo MA
Mol Cell Endocrinol; 2013 Jun; 372(1-2):105-15. PubMed ID: 23545157
[TBL] [Abstract][Full Text] [Related]
26. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
[TBL] [Abstract][Full Text] [Related]
27. 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib.
Girgert R; Emons G; Gründker C
Oncol Rep; 2017 Feb; 37(2):1212-1218. PubMed ID: 27959426
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells.
Zhang H; Wang X; Chen Z; Wang W
Cell Mol Biol (Noisy-le-grand); 2015 Nov; 61(7):96-101. PubMed ID: 26638889
[TBL] [Abstract][Full Text] [Related]
29. GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts.
Luo H; Yang G; Yu T; Luo S; Wu C; Sun Y; Liu M; Tu G
Endocr Relat Cancer; 2014 Apr; 21(2):355-69. PubMed ID: 24481325
[TBL] [Abstract][Full Text] [Related]
30. Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.
Marchese S; Silva E
PLoS One; 2012; 7(10):e45767. PubMed ID: 23056216
[TBL] [Abstract][Full Text] [Related]
31. A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells.
Liu H; Yan Y; Wen H; Jiang X; Cao X; Zhang G; Liu G
Cell Biol Int; 2014 May; 38(5):631-8. PubMed ID: 24446390
[TBL] [Abstract][Full Text] [Related]
32. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
33. The activation of the G protein-coupled estrogen receptor (GPER) inhibits the proliferation of mouse melanoma K1735-M2 cells.
Ribeiro MPC; Santos AE; Custódio JBA
Chem Biol Interact; 2017 Nov; 277():176-184. PubMed ID: 28947257
[TBL] [Abstract][Full Text] [Related]
34. G protein-coupled estrogen receptor activation by bisphenol-A disrupts the protection from apoptosis conferred by the estrogen receptors ERα and ERβ in pancreatic beta cells.
Babiloni-Chust I; Dos Santos RS; Medina-Gali RM; Perez-Serna AA; Encinar JA; Martinez-Pinna J; Gustafsson JA; Marroqui L; Nadal A
Environ Int; 2022 Jun; 164():107250. PubMed ID: 35461094
[TBL] [Abstract][Full Text] [Related]
35. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells.
Lappano R; Rosano C; Santolla MF; Pupo M; De Francesco EM; De Marco P; Ponassi M; Spallarossa A; Ranise A; Maggiolini M
Curr Cancer Drug Targets; 2012 Jun; 12(5):531-42. PubMed ID: 22414008
[TBL] [Abstract][Full Text] [Related]
36. Insight into the mechanism of tetrachlorobisphenol A (TCBPA)-induced proliferation of breast cancer cells by GPER-mediated signaling pathways.
Lei B; Tang Q; Sun S; Zhang X; Huang Y; Xu L
Environ Pollut; 2021 Apr; 275():116636. PubMed ID: 33582643
[TBL] [Abstract][Full Text] [Related]
37. Differential Effects of the G-Protein-Coupled Estrogen Receptor (GPER) on Rat Embryonic (E18) Hippocampal and Cortical Neurons.
Pemberton K; Rosato M; Dedert C; DeLeon C; Arnatt C; Xu F
eNeuro; 2022; 9(4):. PubMed ID: 35788105
[TBL] [Abstract][Full Text] [Related]
38. GPER-induced signaling is essential for the survival of breast cancer stem cells.
Chan YT; Lai AC; Lin RJ; Wang YH; Wang YT; Chang WW; Wu HY; Lin YJ; Chang WY; Wu JC; Yu JC; Chen YJ; Yu AL
Int J Cancer; 2020 Mar; 146(6):1674-1685. PubMed ID: 31340060
[TBL] [Abstract][Full Text] [Related]
39. [Influence of pertussis toxin on GPER-mediated activation of phosphatidylinositol 3-kinase/protein kinase B signaling induced by 17β-estradiol in endometrial carcinoma cells].
Guo RX; Lei J; Wang XY; Ge X; Hu DM; Ma XY; Li LX; Qiao YH
Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):129-33. PubMed ID: 23544495
[TBL] [Abstract][Full Text] [Related]
40. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]